SMIB: Mission Cure - Steam Copies Sold & Revenue Statistics
Game information
Game information
Category Ranking History -
Steam Copies Sold & Revenue by Player Language
Game context & FAQ
Steam list price (this language tier)
USD storefront tier (default international): $1.99. USD reference tier: $1.99.
Quick answers
- What Steam list-price tier does GameSensor mirror for SMIB: Mission Cure on this localized page?
- Our snapshot on 2026-06-05 shows about $1.99 for the storefront tier paired with this language view, alongside a USD tier of $1.99. Those are informational list tiers before VAT or running discounts.
- How are Steam copies sold and gross revenue computed?
- They’re modeled estimates from Steam review throughput, inferred player languages, historical price ladders per currency, and whether the SKU was temporarily free-not official Valve financials. See the indie methodology guide for formulas.
- Where do I find language mix data for SMIB: Mission Cure?
- Look for “Steam Copies Sold & Revenue by Player Language” above; it breaks review volume down by Steam’s detected languages, which also drives our regional revenue weighting.
Information
SMIB: Mission Cure was released on Steam on November 19, 2020 and has been available for 7 months.
According to GameSensor analytics, in May 2026, the game sold >1K copies, generating a total Steam revenue of >$5K. These numbers reflect strong interest from players and steady commercial performance.
This is the 2th title released by Virtual Arts Studio, demonstrating consistent production output and a stable release cycle.
A key factor driving the performance of SMIB: Mission Cure is its international audience. The Steam player-language distribution shows that users primarily play the game in:
• English
• French
• German.
Language distribution directly affects buying behavior, regional sales peaks, and long-term retention. Games with a diverse multilingual audience usually demonstrate stronger global performance and broader revenue stability.
The current Steam user rating for SMIB: Mission Cure is positively.
Compared to the studio’s previous release - Magicolors - the game currently holds a lower rating. Its sales performance is 337% lower relative to Magicolors over the same number of days after release.
Overall, sales are 1375% lower compared to the average performance of the last 4 paid titles released by Virtual Arts Studio. This comparison helps position SMIB: Mission Cure within the studio’s broader commercial history.
Within the full catalog of the publisher Virtual Arts Studio, SMIB: Mission Cure currently ranks 5 among the most financially successful projects

SMIB: Mission Cure: the storefront tied to USD storefront tier (default international) shows $1.99 as of 2026-06-05, with USD reference $1.99. We plug these tracked tiers into the review-based gross model.